Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sanofi and Regeneron, seeking to shield Dupixent, lose first IPR try against Amgen
Sanofi and Regeneron, seeking to shield Dupixent, lose first IPR try against Amgen
Sanofi and Regeneron, seeking to shield Dupixent, lose first IPR try against Amgen
Submitted by
admin
on October 5, 2017 - 9:34am
Source:
Fierce Pharma
News Tags:
Sanofi
Regeneron
Dupixent
IPR
Amgen
patents
Headline:
Sanofi and Regeneron, seeking to shield Dupixent, lose first IPR try against Amgen
Do Not Allow Advertisers to Use My Personal information
